Evidence map›Paper›PMID 29796222›Full record

ArticleIranian journal of basic medical sciences2018

Development of monoclonal antibodies against axenic amastigotes of

Ezzat Nourizadeh, Seyed Jalal Zargar, Mohammad Hossein Alimohammadian, Soheila Ajdary, Mahdi Mahdavi

Abstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ezzat NourizadehSchool of Biology, College of Science, University of Tehran, Tehran, Iran.
Seyed Jalal ZargarSchool of Biology, College of Science, University of Tehran, Tehran, Iran.
Mohammad Hossein AlimohammadianDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Soheila AjdaryDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.
Mahdi MahdaviDepartment of Immunology, Pasteur Institute of Iran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLeishmaniasis is endemic in 88 countries. Amastigote forms of MATERIALS AND

methodsFirst, standard strains were cultured and axenic amastigote antigens of

resultsApproximately 25 positive monoclones were obtained, of which four hybrids producing anti-amastigotes

conclusionThis study produced monoclonal antibody against amastigotes of Iranian strain of

Indexed as

Axenic amastigotesHybridoma cellsLeishmania infantumLeishmaniasesMonoclonal antibodies

Identifiers

PMID29796222
PMCPMC5960755

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.